Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Gastroenterology & Hepatology|October 13, 2006
Miscellaneous indications for transjugular intrahepatic portosystemic stent-shuntGeorge Therapondos, Florence Wong
Hepatology (Baltimore, Md.)|August 31, 2006
The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosisGeorge Therapondos, Lieke Hol, Fabiana Benjaminov, et al.
Journal of Gastroenterology and Hepatology|December 17, 2003
Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot studyGeorge Therapondos, Adrian J Stanley, Peter C Hayes
Nature Reviews. Nephrology|November 15, 2019
Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosisJuan Carlos Q Velez, George Therapondos, Luis A Juncos
Nature Reviews. Nephrology|January 29, 2020
Author Correction: Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosisJuan Carlos Q Velez, George Therapondos, Luis A Juncos
Cureus|December 7, 2020
The Utilization and Diagnostic Yield of Upper Endoscopy for Evaluation of Gastrointestinal Symptoms Within the First Year After Liver TransplantationEbubekir Daglilar, Sean E Connolly, Veysel Tahan, et al.
Clinical Science (London, England : 1979)|March 18, 2003
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosisJames Walter Ferguson, George Therapondos, David E Newby, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Cardiac morbidity and mortality related to orthotopic liver transplantationGeorge Therapondos, Andrew D Flapan, John N Plevris, et al.
Gastro Hep Advances|July 21, 2025
A Real-World Experience With Resmetirom: Tolerability and AccessSameera Shuaibi, Ian Tobal, James Gore, et al.
Canadian Journal of Gastroenterology & Hepatology|November 12, 2013
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantationTomohiro Tanaka, Eberhard L Renner, Nazia Selzner, et al.
Pageof 7